Outpatient data noted that over 80% of users reported significant weight loss and a 10% reduction in waist circumference
Its manufacturing and storage are more streamlined, and its oral administration is more convenient, as it eliminates the need for a 30-minute fasting window
Quick, convenient treatment Injections take only minutes and bypass the digestive system for direct absorption
Compounded products are not FDA-approved, and FDA-approved alternatives are available for patients to discuss with a licensed healthcare professional
Judge Marstons August 15, 2025 ruling clarified: Clinical diagnosis based solely on symptoms is not sufficient You must have objective diagnostic testing Specifically: gastric emptying scan (4-hour scintigraphy study) Alternative tests: gastric emptying breath test or wireless motility capsule (SmartPill, though discontinued) Why this matters: Many patients were told they had gastroparesis based only on symptoms Without objective testing, defendants will challenge the diagnosis Court ruled that symptom-based diagnosis isnt reliable enough Need scientific proof of delayed gastric emptying What if you have symptoms but no formal testing
This was a 46% reduction in risk for those treated with tirzepatide